Trial Profile
Clinical Trials Insight: 700011661
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Feb 2009
Price :
$35
*
At a glance
- Drugs Nalbuphine (Primary)
- Indications Dental pain; Postoperative pain
- Focus Therapeutic Use
- Sponsors Endo Pharmaceuticals
- 31 Jan 2006 New trial record.